UnknownNCT03559374

Study of Vanadis® NIPT for Non-invasive Prenatal Screening of Trisomies (T21, T18 and T13)

Studying Down syndrome

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
PerkinElmer, Wallac Oy
Principal Investigator
Enza Pavanello
Centro Screening neonatale e prenatale del Piemonte e Valle d'Aosta AOU Città della Salute e della Scienza di Torino
Intervention
Vanadis NIPT system(other)
Enrollment
1200 enrolled
Eligibility
18-55 years · FEMALE
Timeline
2018 – 2020

Study locations (1)

Collaborators

A.O.U. Città della Salute e della Scienza

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03559374 on ClinicalTrials.gov

Other trials for Down syndrome

Additional recruiting or active studies for the same condition.

See all trials for Down syndrome →

← Back to all trials